SCHEMBL1401052

SCHEMBL1401052

COC(=O)c1ccccc1CC[C@H](Cl)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14417298 1.00 — —
SCHEMBL14294824 1.00 — —
SCHEMBL1592252 1.00 — —
SCHEMBL202013 0.92 — —
SCHEMBL202015 0.92 — —
SCHEMBL8761819 0.92 — —
SCHEMBL457832 0.92 — —
SCHEMBL2734687 0.92 — —
SCHEMBL202012 0.92 — —
SCHEMBL202014 0.92 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1812393-B1 METHYL 2-[(3S)-[3-[(2E)-(7-CHLOROQUINOLIN-2-YL) ETHENYL]PHENYL]-3-HALOPROPYL]-BENZOATE ESTER MATRIX LAB LTD (IN) 2011-12-28 — — EP claimed
US-7858793-B2 Methyl 2-[(3S)-[3-[2E)-(7-chloro quinolin-2-yl) ethenyl] phenyl]-3-halopropyl] benzoates SATYANARAYANA CHAVA 2010-12-28 — — US claimed
US-20080275243-A1 Process for the Preparation of Polymorphs, Solvates of Aripiprazole Using Aripiprazole Acid Salts SATYANARAYANA CHAVA 2008-11-06 — — US claimed
EP-1940793-A2 A PROCESS FOR THE PREPARATION OF MONTELUKAST Matrix Laboratories Ltd (IN) 2008-07-09 — — EP claimed
EP-1812393-A2 \"METHYL 2-[(3S)-[3-[(2E)-(7-CHLORO QUINOLIN-2-YL) ETHENYL] PHENYL]-3-HALOPROPYL] BENZOATES&amp;rdquo; Matrix Laboratories Ltd (IN) 2007-08-01 — — EP claimed
EP-1812394-A2 PROCESS FOR THE PREPARATION OF MONTELUKAST AND ITS SALTS Matrix Laboratories Ltd (IN) 2007-08-01 — — EP claimed
WO-2007004237-A2 A PROCESS FOR THE PREPARATION OF MONTELUKAST MATRIX LABORATORIES LTD (IN) 2007-01-11 — — WO claimed
WO-2006008750-A2 METHYL 2-[(3S)-[3-[(2E)-(7-CHLORO QUINOLIN-2-YL) ETHENYL] PHENYL]-3-HALOPROPYL] BENZOATES MATRIX LABORATORIES LTD (IN) 2006-01-26 — — WO claimed
WO-2006008751-A2 PROCESS FOR THE PREPARATION OF MONTELUKAST AND ITS SALTS MATRIX LABORATORIES LTD (IN) 2006-01-26 — — WO claimed
EP-1812393-B1 METHYL 2-[(3S)-[3-[(2E)-(7-CHLOROQUINOLIN-2-YL) ETHENYL]PHENYL]-3-HALOPROPYL]-BENZOATE ESTER MATRIX LAB LTD (IN) 2011-12-28 — — EP disclosed
US-20110137039-A1 PROCESS FOR THE PREPARATION OF MONTELUKAST AND ITS SALTS MYLAN LABORATORIES LIMITED (IN) 2011-06-09 — — US disclosed
US-20110092708-A1 PROCESS FOR THE PREPARATION OF MONTELUKAST AND ITS SALTS THEREOF MYLAN LABORATORIES LIMITED (IN) 2011-04-21 — — US disclosed
US-20110092708-A1 PROCESS FOR THE PREPARATION OF MONTELUKAST AND ITS SALTS THEREOF MYLAN LABORATORIES LIMITED (IN) 2011-04-21 — — US disclosed
EP-1812394-B1 PROCESS FOR THE PREPARATION OF MONTELUKAST AND ITS SALTS MATRIX LAB LTD (IN) 2011-03-02 — — EP disclosed
WO-2008015703-A2 PROCESS FOR THE PREPARATION OF MONTELUKAST AND ITS SALTS THEREOF MATRIX LABORATORIES LTD (IN) 2008-02-07 — — WO disclosed
EP-1812393-A2 \"METHYL 2-[(3S)-[3-[(2E)-(7-CHLORO QUINOLIN-2-YL) ETHENYL] PHENYL]-3-HALOPROPYL] BENZOATES&amp;rdquo; Matrix Laboratories Ltd (IN) 2007-08-01 — — EP disclosed
EP-1812394-A2 PROCESS FOR THE PREPARATION OF MONTELUKAST AND ITS SALTS Matrix Laboratories Ltd (IN) 2007-08-01 — — EP disclosed
WO-2007004237-A2 A PROCESS FOR THE PREPARATION OF MONTELUKAST MATRIX LABORATORIES LTD (IN) 2007-01-11 — — WO disclosed
WO-2006008750-A2 METHYL 2-[(3S)-[3-[(2E)-(7-CHLORO QUINOLIN-2-YL) ETHENYL] PHENYL]-3-HALOPROPYL] BENZOATES MATRIX LABORATORIES LTD (IN) 2006-01-26 — — WO disclosed
WO-2006008751-A2 PROCESS FOR THE PREPARATION OF MONTELUKAST AND ITS SALTS MATRIX LABORATORIES LTD (IN) 2006-01-26 — — WO disclosed
Send feedback